| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/23/2001 | EP1100807A1 STEREOISOMERS OF CpG OLIGONUCLEOTIDES AND RELATED METHODS |
| 05/23/2001 | EP1100805A1 Medicine nitrate salts |
| 05/23/2001 | EP1100803A2 Pyrrolo 2,1-b] 1,3]benzothiazepines with atypical antipsychotic activity |
| 05/23/2001 | EP1100802A1 OXAZOLO, THIAZOLO AND SELENAZOLO [4,5-c]-QUINOLIN-4-AMINES AND ANALOGS THEREOF |
| 05/23/2001 | EP1100801A2 Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric g protein |
| 05/23/2001 | EP1100800A1 Novel c-2 s/o- and s/n formaldehyde acetal derivatives of carbapenem-3-carboxylic acids and their use as antibiotics and beta-lactamase inhibitors |
| 05/23/2001 | EP1100797A1 Heterocyclic compounds as inhibitors of rotamase enzymes |
| 05/23/2001 | EP1100796A1 Process for the preparation of a non-crystalline anhydrate form of paroxetine hydrochloride |
| 05/23/2001 | EP1100795A1 Disubstituted bicyclic heterocycles having, in particular, a thrombin inhibitive effect |
| 05/23/2001 | EP1100794A1 COMPOUNDS SPECIFIC FOR THE HUMAN $g(a) 1d? ADRENERGIC RECEPTOR AND USES THEREOF |
| 05/23/2001 | EP1100792A1 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 05/23/2001 | EP1100790A1 Antidiabetic piperazine derivatives, processes for their preparation and compositions containing them |
| 05/23/2001 | EP1100788A1 Substituted quinazoline derivatives |
| 05/23/2001 | EP1100787A1 Lipid-lowering quinazoline derivative |
| 05/23/2001 | EP1100786A1 Antiviral pyrimidinedione derivatives and process for the preparation thereof |
| 05/23/2001 | EP1100781A1 High affinity ligands for nociceptin receptor orl-1 |
| 05/23/2001 | EP1100780A1 Novel 2,3,3a,4,9,9a hexahydro-8-hydroxy-1h-benz f]indoles, a method for the production thereof, and their use as medicaments |
| 05/23/2001 | EP1100779A1 Substituted indolinones, the production thereof and their use as medicaments |
| 05/23/2001 | EP1100778A1 Oxidised sulfurated distamycin derivatives, process for preparing them, and their use as antitumor agents |
| 05/23/2001 | EP1100777A1 Sulfurated distamycin derivatives, process for preparing them, and their use as antitumor agents |
| 05/23/2001 | EP1100775A2 2,5-substituted benzolsulfonylureas and thioureas, methods for the production thereof, use thereof and pharmaceutical preparations containing the same |
| 05/23/2001 | EP1100771A1 Compounds and compositions for delivering active agents |
| 05/23/2001 | EP1100769A1 Aminomethylcarboxylic acid derivatives |
| 05/23/2001 | EP1100767A1 Novel phenylethylamine derivatives, a method for the production thereof and their use as medicaments |
| 05/23/2001 | EP1100763A1 Diketoacid-derivatives as inhibitors of polymerases |
| 05/23/2001 | EP1100589A2 Use of l-carnitine and its alkanoyl derivatives in the preparation of medicaments with anticancer activity |
| 05/23/2001 | EP1100547A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease |
| 05/23/2001 | EP1100542A2 Peg-urate oxidase conjugates and use thereof |
| 05/23/2001 | EP1100539A2 Combination of active substances, especially for the prophylaxis and therapy of ischaemic organic lesions and reperfusion syndromes |
| 05/23/2001 | EP1100522A1 Pulmonary delivery of active agents |
| 05/23/2001 | EP1100521A1 C7f2-a novel potassium channel beta-subunit |
| 05/23/2001 | EP1100519A1 Multibinding agents that modulate nmda receptors |
| 05/23/2001 | EP1100518A1 COMPOSITION AND METHOD OF TREATING DISEASE WITH EXTRACT OF $i(MUSACEAS) |
| 05/23/2001 | EP1100517A1 Nutrient and therapeutic compositions for the treatment of cancer |
| 05/23/2001 | EP1100513A1 Autoinducer synthase modulating compounds and uses therefor |
| 05/23/2001 | EP1100512A2 Preparation of thioarabinofuranosyl compounds and use thereof |
| 05/23/2001 | EP1100511A2 Inhibition of delta-9-desaturase activity by saponins |
| 05/23/2001 | EP1100510A2 Combined preparation of anti-infectiously active compounds which inhibit the 2-c-methylerythrose-4 metabolic pathway, and inhibitors of lipid metabolism |
| 05/23/2001 | EP1100509A1 Use of biogenic estrogen sulfamates for hormone replacement therapy |
| 05/23/2001 | EP1100508A2 Pharmaceutical combination comprising a tricyclic compound and at least one of zolpidem, zopiclone, triazolam and brotizolam for treating or preventing sleep disorders |
| 05/23/2001 | EP1100507A1 Antioxidant composition and method of treating diseases using same |
| 05/23/2001 | EP1100506A1 Integrin receptor antagonists |
| 05/23/2001 | EP1100505A1 A PHARMACEUTICAL COMBINATION COMPRISING A COX-2 INHIBITOR AND A iNOS INHIBITOR |
| 05/23/2001 | EP1100504A2 Pharmaceutical compositions and their uses for treatment of demyelinating disorders |
| 05/23/2001 | EP1100503A2 Non-imidazole alkylamines as histamine h 3?-receptor ligands and their therapeutic applications |
| 05/23/2001 | EP1100502A1 Methods and compositions for treating gastro-esophageal reflux disease |
| 05/23/2001 | EP1100501A1 Pyrrolidine and pyrroline derivatives having effects on serotonin related systems |
| 05/23/2001 | EP1100500A1 The use of cd4-binding small molecules to inhibit hiv infection |
| 05/23/2001 | EP1100499A1 Prevention of migraine recurrence |
| 05/23/2001 | EP1100498A1 Heterocyclic sulphonamide derivatives |
| 05/23/2001 | EP1100497A1 Heterocyclyl sulphonamide derivatives |
| 05/23/2001 | EP1100496A1 Small molecule inhibitors of bcl-2 proteins |
| 05/23/2001 | EP1100495A1 Propenamides as ccr5 modulators |
| 05/23/2001 | EP1100493A1 INDOLE sPLA 2? INHIBITORS |
| 05/23/2001 | EP1100492A1 INDOLE sPLA 2? INHIBITORS |
| 05/23/2001 | EP1100491A1 Ophthalmic compositions for treating ocular hypertension |
| 05/23/2001 | EP1100490A2 Short contact treatment of acne and photoaging with topical retinoids |
| 05/23/2001 | EP1100489A1 Method of altering nutritional components of milk produced by a lactating animal |
| 05/23/2001 | EP1100488A1 Use of creatine compounds for treatment of bone or cartilage cells and tissues |
| 05/23/2001 | EP1100487A2 Compositions for treating diseases associated with glycosaminoglycan-associated molecular interactions |
| 05/23/2001 | EP1100486A1 Macrophage scavenger receptor antagonists |
| 05/23/2001 | EP1100485A1 Substituted anilide compounds and methods |
| 05/23/2001 | EP1100484A1 Macrophage scavenger receptor antagonists |
| 05/23/2001 | EP1100483A2 Glucocorticoid-selective anti-inflammatory agents |
| 05/23/2001 | EP1100482A1 Use of calix(n)arenes for treating fibrotic diseases |
| 05/23/2001 | EP1100481A2 Pharmaceutical formulations comprising beclomethasone dipropionate for the treatment of inflammatory bowel disease |
| 05/23/2001 | EP1100480A2 Cholinergic agents in the treatment of presbyopia |
| 05/23/2001 | EP1100478A1 Estradiol-containing patch for transdermal administration of hormones |
| 05/23/2001 | EP1100477A1 Estradiol-containing patch for transdermal administration of hormones |
| 05/23/2001 | EP1100476A1 Formulations for the transdermal administration of fenoldopam |
| 05/23/2001 | EP1100475A1 Use of drug-loaded nanoparticles for the treatment of cancers |
| 05/23/2001 | EP1100472A1 Pharmaceutical compositions comprising ibuprofen and domperidone |
| 05/23/2001 | EP1100471A1 Compressed compositions comprising clarified xanthan gum |
| 05/23/2001 | EP1100470A1 Fast dissolving ibuprofen containing compositions having analgesic activity |
| 05/23/2001 | EP1100469A1 Rapidly disintegrable solid preparation |
| 05/23/2001 | EP1100467A1 Method for making coated gabapentine or pregabaline particles |
| 05/23/2001 | EP1100465A1 Medicinal aerosol formulations |
| 05/23/2001 | EP1100464A1 Lipid emulsion and solid lipid nanoparticle as a gene or drug carrier |
| 05/23/2001 | EP1100462A2 Methods of ophthalmic administration |
| 05/23/2001 | EP1100456A1 Use of ectoine or ectoine derivatives in cosmetic formulations |
| 05/23/2001 | EP1100454A1 Pharmaceutical compositions and methods for managing skin conditions |
| 05/23/2001 | EP1100444A1 Topical anionic salicylate for disorders of the skin |
| 05/23/2001 | EP1100432A1 Novel uses of ascorbyl-phosphoryl-cholesterol and compositions for practicing same |
| 05/23/2001 | EP1100407A1 Composition for freshening nostrils and sinus cavities |
| 05/23/2001 | EP1100344A1 Novel chitosan-containing liquid compositions and methods for their preparation and use |
| 05/23/2001 | EP0900218A4 Heterocyclic compounds |
| 05/23/2001 | EP0861066B1 Improved pseudocatalase composition |
| 05/23/2001 | EP0841897B1 Physically active antimicrobial gel for cosmetic products |
| 05/23/2001 | EP0812835B1 Optically active thiazolidinone derivatives |
| 05/23/2001 | EP0788497B1 Bisarylcarbinol derivatives as inhibitors of leukotriene biosynthesis |
| 05/23/2001 | EP0750614B1 Quinazolinyl-amino derivatives having alpha-antagonist activity |
| 05/23/2001 | EP0722431B1 Oxidized carotenoids, retinoids and related conjugated polyenes, and derived fractions and compounds useful as cell-differentiation inducers, cytostatic agents, and anti-tumor agents |
| 05/23/2001 | EP0689536B1 Naphthalene derivatives |
| 05/23/2001 | EP0683784B1 7,42-bis (o-demethyl) rapamycin |
| 05/23/2001 | EP0669827B1 Compositions for the regulation of cytokine activity |
| 05/23/2001 | EP0631578B1 Itraconazole and saperconazole stereoisomers |
| 05/23/2001 | DE19955803A1 Verwendung von Heparanase-Inhibitoren zur Behandlung von Hersinsuffizienz The use of heparanase inhibitors in the treatment of Hersinsuffizienz |
| 05/23/2001 | DE19955476A1 Bis-basische Verbindungen als Tryptase-Inhibitoren, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel Bis-basic compounds as tryptase inhibitors, to processes for their preparation and their use as medicaments |
| 05/23/2001 | CN1296529A Method for screening therapeutic agents |
| 05/23/2001 | CN1296492A Fatty acid derivatives of bile acids and bile acid derivatives |